Skip to content
Research Article Open access CC BY 4.0

The Nigerian Pharmaceutical Supply Chain: Blockchain Adoption, Counterfeit Drugs and Successful Deployment of COVID-19 Vaccine in Nigeria

Muhammad Jameel Labaran, Mansur Hamma-adama

Journal of Scientific Research and Reports · pp. 20–36 · Published 23 Mar 2021

10.9734/jsrr/2021/v27i230356

Abstract

Aim: Critically investigating the possibility of adopting blockchain technology within the Nigerian pharmaceutical supply chain to curb the supply of counterfeit drugs. Study Design: The study is qualitative in nature and the primary data were fetched through interviews. Place and Duration of the Study: Conducted within Nigeria for a period of 3 months. Methodology: A qualitative method of data collection was adopted in the study, where some stakeholders were interviewed. The interviews were conducted with employees from different pharmaceutical companies and some drug regulatory agencies in Nigeria. Result: Firstly, this study has ascertained the current prevalence of counterfeit drugs and the reasons for that. The study discovers a very high level of counterfeit drugs and some reasons behind that. Secondly, this study has also found some barriers to blockchain adoption, including the fact that the level of awareness of blockchain technology among stakeholders within the Nigerian pharmaceutical supply chain and the regulatory agencies is very low. Conclusion: It was concluded that the efforts put in developing a viable COVID-19 vaccine could be undermined due to the current nature of the Nigerian pharmaceutical supply chain, the nature of porous borders in place, absence of an apparent drug distribution system, among others.  This study also concludes that the supply chain's current structure needs more regulatory and structural interventions by the Nigerian government than blockchain technology. In other words, with the current nature of the supply chain, blockchain technology adoption would not be effective in delivering the said benefits reported by scholars because the atmosphere is not conducive for successful blockchain adoption.

Blockchain adoption counterfeit drugs COVID-19 vaccine Nigeria supply chain

Cited by 20

Blockchain-Enabled Pharmacy Supply Chain Management: Ensuring Transparency and Efficiency

Abisha D, Varshini S, Thejaswini A · 2023 International Conference on Sustainable Communication Networks and Application (ICSCNA) · 2023

Investigating the role of stakeholder engagement for more resilient vaccine supply chains during COVID-19

Yigit Kazancoglu, Muruvvet Deniz Sezer, Melisa Ozbiltekin-Pala · Operations Management Research · 2022

Blockchain Assisted Archimedes Optimization with Machine Learning Driven Drug Supply Management for Pharmaceutical Sector

Shanthi P, K. Venkatesh · 2023 International Conference on Advances in Computing, Communication and Applied Informatics (ACCAI) · 2023

Navigating uncertainty: a qualitative exploration of supply chain risks in Pakistani hospitals in the post-COVID-19 era

Zunaira Sajjad, Afshan Naseem, Asjad Shahzad · Journal of Health Organization and Management · 2025

Blockchain Applications in Sustainable Smart Cities

Zaib Ullah, Muddasar Naeem, Antonio Coronato · Sustainable Cities and Society · 2023

Blockchain Technology for Secure Supply Chain Management: A Comprehensive Review

Udit Agarwal, Vinay Rishiwal, Sudeep Tanwar · IEEE Access · 2022

Evaluating the Factors that Affect the Adoption of Blockchain Technology in the Pharmaceutical Supply Chain - A Case Study from Sri Lanka

Pavani Paththinige, Chathura Rajapakse · 2022 International Research Conference on Smart Computing and Systems Engineering (SCSE) · 2022

Factors Affecting the Pharmaceutical Supply Chain: A Systematic Review

Mohammadkarim Bahadori, Ehsan Teymourzadeh, Sajjad Bahariniya · Health Scope · 2024

Leveraging Digital Transformation for Enhanced Risk Mitigation and Compliance in Pharma Manufacturing

P. Ullagaddi · Journal of Advances in Medical and Pharmaceutical Sciences · 2024

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

20

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.